Pharmacokinetic Dashboard-Recommended Dosing Is Different than Standard of Care Dosing in Infliximab-Treated Pediatric IBD Patients

Marla C. Dubinsky, Becky L. Phan, Namita Singh, Shervin Rabizadeh, Diane R. Mould

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Pharmacokinetic Dashboard-Recommended Dosing Is Different than Standard of Care Dosing in Infliximab-Treated Pediatric IBD Patients'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds